Neuropeptide used in mould-illness and chronic inflammatory protocols.
Typical dose range: 50 mcg
Frequency: 4 × daily intranasal
Route: Intranasal
Half-life: Minutes
Evidence level: Limited clinical
Most associated with the Shoemaker mould-illness protocol. Should only be used after addressing biotoxin exposure.